Catyalyst Pharmaceutical (CPRX) Posts Narrower than Expected Q1 Loss

Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q1 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• Dare Bioscience (DARE) Tops Q2 EPS by 11c